Land Securities Group PLC (LAND)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 656.00 |
|---|---|
| 52-week range | 507.19 – 726.00 |
| Return, 1 month / 3 months | +4.9% / −5.3% |
| Return, 1 year / 3 years | +12.8% / +39.6% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 24.4% |
| Worst drawdown (1 year) | -21.2% |
| Average daily value traded | 2,418.57M GBX |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Land Securities Group is a British property company that owns, develops and manages commercial real estate, chiefly offices in London and shopping centres and retail parks around the United Kingdom. Its customers are businesses and retailers that lease space in its buildings, and it also undertakes large development projects, such as new office schemes in the capital. The company is based in London and operates as a real estate investment trust, deriving income mainly from rents and property management.
Land Securities Group PLC trades under the code LAND on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Land Securities Group PLC (LAND) trades on the London Exchange in UK. It last closed at GBX 656.00 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 657 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.8% and over the last three months it fell 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.1% | ||
| From 52-week high | -9.1% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.3% | ||
| 6-month return | 9.4% | ||
| 12-month return, skipping the last month | 7.6% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.2% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 2,418.57M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +7.3% |
|---|---|
| 1 month | +4.9% |
| 3 months | −5.3% |
| 6 months | +9.4% |
| 1 year | +12.8% |
| 3 years | +39.6% |
| 5 years | +32.0% |
Signals
| 50-day / 200-day average | 650.75 / 624.46 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 13.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Jun 2026 | GBP 0.2220 |
| 27 Nov 2025 | GBP 0.1900 |
| 12 Jun 2025 | GBP 0.1230 |
| 20 Feb 2025 | GBP 0.0950 |
| 28 Nov 2024 | GBP 0.0940 |
| 22 Aug 2024 | GBP 0.0920 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.